DrugPatentWatch Database Preview

Ixazomib citrate - Generic Drug Details

What are the generic drug sources for ixazomib citrate and what is the scope of ixazomib citrate freedom to operate?

Ixazomib citrate is the generic ingredient in one branded drug marketed by Millennium Pharms and is included in one NDA. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for ixazomib citrate

US Patents:	9
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	17
Clinical Trials:	22
Patent Applications:	4
DailyMed Link:	ixazomib citrate at DailyMed

Pharmacology for ixazomib citrate

Drug Class	Proteasome Inhibitor
Mechanism of Action	Proteasome Inhibitors

Synonyms for ixazomib citrate

1,3,2-Dioxaborolane-4,4-diacetic acid, 2-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-5-oxo-
1239908-20-3
2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid
2,2'-{2-[(1R)-1-({[(2,5-dichlorobenzoy)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid
2,2'-{2-[(1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid
2,2'-{2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid
46CWK97Z3K
AKOS030632768
CHEBI:90939
CHEMBL3545432
CS-1720
D10131
FT-0699809
HY-10452
Ixazomib citrate (Ester)
Ixazomib citrate (JAN/USAN)
Ixazomib citrate [USAN]
KS-00000TRH
MBOMYENWWXQSNW-AWEZNQCLSA-N
MolPort-044-560-850
Ninlaro (TN)
SCHEMBL4427479
UNII-46CWK97Z3K
ZINC200299610

US Patents and Regulatory Information for ixazomib citrate

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Millennium Pharms	NINLARO	ixazomib citrate	CAPSULE;ORAL	208462-003	Nov 20, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y	Y		➤ Sign Up
Millennium Pharms	NINLARO	ixazomib citrate	CAPSULE;ORAL	208462-003	Nov 20, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Millennium Pharms	NINLARO	ixazomib citrate	CAPSULE;ORAL	208462-001	Nov 20, 2015		RX	Yes	No	➤ Sign Up	➤ Sign Up	Y	Y		➤ Sign Up
Millennium Pharms	NINLARO	ixazomib citrate	CAPSULE;ORAL	208462-001	Nov 20, 2015		RX	Yes	No	➤ Sign Up	➤ Sign Up	Y	Y		➤ Sign Up
Millennium Pharms	NINLARO	ixazomib citrate	CAPSULE;ORAL	208462-003	Nov 20, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for ixazomib citrate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Georgia, Republic of	P20135847	➤ Sign Up
Taiwan	I440641	➤ Sign Up
Taiwan	200529810	➤ Sign Up
China	102066386	➤ Sign Up
Hong Kong	1091839	➤ Sign Up
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for ixazomib citrate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2017 00014	Denmark	➤ Sign Up	PRODUCT NAME: IXAZOMIB OG FARMACEUTISK ACCEPTABLE SALTE DERAF, HERUNDER IXAZOMIBCITRAT; REG. NO/DATE: EU/1/16/1094 20161123
0871	Netherlands	➤ Sign Up	PRODUCT NAME: IXAZOMIB EN FARMACEUTISCH AANVAARDBARE ZOUTEN EN ESTERS DAARVAN, ZOALS IXAZOMIBCITRAAT; REGISTRATION NO/DATE: EU/1/16/1094 20161123
2017010,C2178888	Lithuania	➤ Sign Up	PRODUCT NAME: IKSAZOMIBAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA IR ESTERIS, TOKS KAIP IKSAZOMIBO CITRATAS; REGISTRATION NO/DATE: EU/1/16/1094 20161121
0170014 00227	Estonia	➤ Sign Up	PRODUCT NAME: IKSASOMIIB;REG NO/DATE: EU/1/16/1094 23.11.2016
2017010	Lithuania	➤ Sign Up	PRODUCT NAME: IKSAZOMIBAS ARBA JO FARMACINIU POZIURIU PRIIMTINOS DRUSKOS IR ESTERIAI, PAVYZDZIUI KAIP IKSAZOMIBO CITRATAS; REGISTRATION NO/DATE: EU/1/16/1094 20161121
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description